Kindling Bio
Founded 2025 · 2 employees on LinkedIn · 1 known investors
Find your way into Kindling Bio
1 people in our graph share verified history with the Kindling Bio team — schools, employers, funds. One of them is your warm intro.
Kindling Bio develops targeted cancer gene therapy for children that uses the immune system to fight a range of tumors. The company focuses on pediatric oncology, aiming to replace toxic adult-designed therapies with treatments tailored to children's biology.
Founders & leadership
Kindling Bio was founded in 2025 by Jeff Drew.
JD
Jeff DrewinCo-FounderJeff Drew, founder of Kindling Bio, has more than 30 years of experience spanning virology, molecular biology, immunology, and stem cell research, including 23 years in industry. He has led programs from discovery through clinical-stage vaccine development and GMP manufacturing, contributed to over 100 patent filings, and previously provided scientific leadership to an oncology therapy company. Kindling Bio develops targeted gene therapy for pediatric cancers that harnesses the immune system to treat a range of tumors.
Investors · 1
In the news
Frequently asked questions
- What does Kindling Bio do?
- Kindling Bio develops targeted cancer gene therapy for children that uses the immune system to fight a range of tumors. The company focuses on pediatric oncology, aiming to replace toxic adult-designed therapies with treatments tailored to children's biology.
- Who founded Kindling Bio?
- Kindling Bio was founded by Jeff Drew in 2025.
- Who are Kindling Bio's investors?
- Kindling Bio's investors include Deep Science Ventures.